Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.
Who will be affected?
Readers: No access to all 28 journals. We recommend accessing our articles via PubMed Central
Authors: No access to the submission form or your user account.
Reviewers: No access to your user account. Please download manuscripts you are reviewing for offline reading before Wednesday, July 01, 2020 at 7:00 PM.
Editors: No access to your user account to assign reviewers or make decisions.
Copyeditors: No access to user account. Please download manuscripts you are copyediting before Wednesday, July 01, 2020 at 7:00 PM.
Indications for Medical Cannabis and Their Alignment With US-Wide Disease Prevalences in the US’ Largest Medical Cannabis Program: Cross-Sectional Study
Indications for medical cannabis and their alignment with US-wide disease prevalences in the US’ largest medical cannabis program: A cross-sectional study
Sebastian Jugl;
Nicole Smolinski;
Tansu Aydogan;
Almut Winterstein
ABSTRACT
Background:
This research letter compared the prevalence of qualifying conditions among Florida medical cannabis patients to population-based prevalence estimates for the same conditions and observed marked discrepancies. These findings highlight conditions that appear to be significant reasons for patients to consider medical cannabis, providing important research priorities for future research on its effectiveness and safety.
Objective:
NA
Methods:
NA
Results:
NA
Conclusions:
NA Clinical Trial: NA
Citation
Please cite as:
Jugl S, Smolinski N, Aydogan T, Winterstein A
Indications for Medical Cannabis and Their Alignment With US-Wide Disease Prevalences in the US’ Largest Medical Cannabis Program: Cross-Sectional Study